Sanofi to purchase Pluromed
Sanofi will commercialize Pluromed’s LeGoo, a gel indicated for temporary endovascular occlusion of blood vessels during surgical procedures. LeGoo is a FDA approved and CE marked product. This
The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) to treat adults with primary membranous nephropathy (pMN).
The expansion features approximately 49,000ft² of distribution space and 8,000ft² of packaging space. The existing campus will continue to facilitate the administrative offices, sales, marketing and distribution functions